申请人:Aventis Pharma Deutschland GmbH
公开号:US06326487B1
公开(公告)日:2001-12-04
Novel oligonucleotide analogs of the formulae I and II
in which A, B, D, R1, R2, T, U, V, W, X, Y, Z, a, b, m, m′, n and n′ have the meanings stated in the description, with valuable physical, biological and pharmacological properties, and a process for the preparation thereof are described. Application thereof relates to the use as inhibitors of gene expression (antisense oligonucleotides, ribozymes, sense oligonucleotides and triplex forming oligonucleotides), as probes for detecting nucleic acids and as aids in molecular biology.
本发明描述了式I和式II的新型寡核苷酸类似物,其中A、B、D、R1、R2、T、U、V、W、X、Y、Z、a、b、m、m'、n和n'具有所述描述中给出的含义,具有有价值的物理、
生物和药理特性,并提供了其制备方法。其应用涉及作为
基因表达
抑制剂(反义寡核苷酸、核酶、正义寡核苷酸和三重螺旋寡核苷酸),作为检测核酸的探针以及在
分子生物学中的辅助工具。